These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27804036)

  • 1. Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.
    Noto D; Arca M; Tarugi P; Cefalù AB; Barbagallo CM; Averna MR
    Acta Diabetol; 2017 Feb; 54(2):111-122. PubMed ID: 27804036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.
    Di Costanzo A; Di Leo E; Noto D; Cefalù AB; Minicocci I; Polito L; D'Erasmo L; Cantisani V; Spina R; Tarugi P; Averna M; Arca M
    J Clin Lipidol; 2017; 11(5):1234-1242. PubMed ID: 28733173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
    Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL.
    Yue P; Isley WL; Harris WS; Rosipal S; Akin CD; Schonfeld G
    Atherosclerosis; 2005 Jan; 178(1):107-13. PubMed ID: 15585207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation.
    Martín-Campos JM; Roig R; Mayoral C; Martinez S; Martí G; Arroyo JA; Julve J; Blanco-Vaca F
    Clin Chim Acta; 2012 Mar; 413(5-6):552-5. PubMed ID: 22155345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia.
    Sankatsing RR; Fouchier SW; de Haan S; Hutten BA; de Groot E; Kastelein JJ; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1979-84. PubMed ID: 16002743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature.
    Cefalù AB; Norata GD; Ghiglioni DG; Noto D; Uboldi P; Garlaschelli K; Baragetti A; Spina R; Valenti V; Pederiva C; Riva E; Terracciano L; Zoja A; Grigore L; Averna MR; Catapano AL
    Atherosclerosis; 2015 Mar; 239(1):209-17. PubMed ID: 25618028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease.
    Welty FK
    Curr Opin Lipidol; 2020 Apr; 31(2):49-55. PubMed ID: 32039990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.
    Gutiérrez-Cirlos C; Ordóñez-Sánchez ML; Tusié-Luna MT; Patterson BW; Schonfeld G; Aguilar-Salinas CA
    Ann Hepatol; 2011; 10(2):155-64. PubMed ID: 21502677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia.
    Rimbert A; Pichelin M; Lecointe S; Marrec M; Le Scouarnec S; Barrak E; Croyal M; Krempf M; Le Marec H; Redon R; Schott JJ; Magré J; Cariou B
    Atherosclerosis; 2016 Jul; 250():52-6. PubMed ID: 27179706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
    Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
    Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
    J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypobetalipoproteinemia: genetics and metabolism.
    Schonfeld G; Lin X; Yue P
    Cell Mol Life Sci; 2005 Jun; 62(12):1372-8. PubMed ID: 15818469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene.
    Tada H; Okada H; Nomura A; Nohara A; Takamura M; Kawashiri MA
    Intern Med; 2020; 59(6):783-787. PubMed ID: 32173689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population.
    Yue P; Averna M; Lin X; Schonfeld G
    Hum Mutat; 2006 May; 27(5):460-6. PubMed ID: 16619215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
    Hooper AJ; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PHR; van Bockxmeer FM; Burnett JR
    Clin Biochem; 2016 Jun; 49(9):720-722. PubMed ID: 26916057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
    Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
    Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric gallstone disease in familial hypobetalipoproteinemia.
    Lancellotti S; Zaffanello M; Di Leo E; Costa L; Lonardo A; Tarugi P
    J Hepatol; 2005 Jul; 43(1):188-91. PubMed ID: 15894400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.